Compound details
Koaburanin
| Compound ID | CDAMM01217 |
|---|---|
| Common name | Koaburanin | IUPAC name | 2-(hydroxymethyl)-6-[(5-hydroxy-2-phenyl-3,4-dihydro-2H-chromen-7-yl)oxy]oxane-3,4,5-triol |
| Molecular formula | C21H24O8 |
| Retention time | 0.47 |
|---|---|
| Adduct | [2M+K]+ |
| Actual mz | 847.254 | Theoretical mz | 847.257 |
| Error | 3.61 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.9762 |
| Inchi key | AAHNTCWRJBNODQ-YWZRKEQENA-N |
|---|---|
| Smiles | OC=1C=C(OC2OC(CO)C(O)C(O)C2O)C=C3OC(C=4C=CC=CC4)CCC13 |
| Superclass | Phenylpropanoids and polyketides |
| Class | Flavonoids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| O43570 | CA12 | Carbonic anhydrase XII | T16987 | SEA |
| Q16790 | CA9 | Carbonic anhydrase IX | T64567 | SEA |
| P15692 | VEGFA | Vascular endothelial growth factor A | T20761 | SEA |
| P05230 | FGF1 | Acidic fibroblast growth factor | T18639 | SEA |
| P09038 | FGF2 | Basic fibroblast growth factor | T31621 | SEA |
| P01112 | HRAS | Transforming protein p21/H-Ras-1 | T71081 | SEA |
| P60568 | IL2 | Interleukin-2 | T61698 | SEA |
| P17931 | LGALS3 | Galectin-3 | T72038 | SEA |
| P14679 | TYR | Tyrosinase | T97035 | SEA |
| P32418 | SLC8A1 | Sodium/calcium exchanger 1 | T07775 | SEA |
| P63316 | TNNC1 | Troponin, cardiac muscle | T12966 | SEA |
| P09382 | LGALS1 | Galectin-1 | T09544 | SEA |
| P01111 | NRAS | GTPase NRas | T35486 | SEA |
| Q9NZ08 | ERAP1 | Endoplasmic reticulum aminopeptidase 1 | T72849 | SEA |
| P05231 | IL6 | Interleukin-6 | T32578 | SEA |
| P30837 | ALDH1B1 | Acetaldehyde dehydrogenase | T99641 | SEA |
| P19429 | TNNI3 | Cardiac troponin I | T20186 | SEA |
| P45379 | TNNT2 | Cardiac muscle troponin T | T05887 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T16987 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | O43570 | CA12 |
| T16987 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | O43570 | CA12 |
| T64567 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q16790 | CA9 |
| T20761 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P15692 | VEGFA |
| T20761 | DI0365 | Retinopathy | [ICD-11: 9B71] | P15692 | VEGFA |
| T20761 | DI0430 | Vascular system developmental anomaly | [ICD-11: LA90] | P15692 | VEGFA |
| T18639 | DI0081 | Chronic arterial occlusive disease | [ICD-11: BD4Z] | P05230 | FGF1 |
| T18639 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | P05230 | FGF1 |
| T31621 | DI0005 | Acne vulgaris | [ICD-11: ED80] | P09038 | FGF2 |
| T61698 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P60568 | IL2 |
| T61698 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P60568 | IL2 |
| T72038 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P17931 | LGALS3 |
| T72038 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P17931 | LGALS3 |
| T72038 | DI0252 | Melanoma | [ICD-11: 2C30] | P17931 | LGALS3 |
| T72038 | DI0302 | Non-alcoholic fatty liver disease | [ICD-11: DB92] | P17931 | LGALS3 |
| T72038 | DI0351 | Psoriasis | [ICD-11: EA90] | P17931 | LGALS3 |
| T97035 | DI0007 | Acquired hypermelanosis | [ICD-11: ED60] | P14679 | TYR |
| T97035 | DI0008 | Acquired hypomelanotic disorder | [ICD-11: ED63] | P14679 | TYR |
| T12966 | DI0006 | Acquired cutaneous blood vessel malformation | [ICD-11: EF20] | P63316 | TNNC1 |
| T12966 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P63316 | TNNC1 |
| T35486 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P01111 | NRAS |
| T35486 | DI0172 | Head and neck cancer | [ICD-11: 2D42] | P01111 | NRAS |
| T35486 | DI0238 | Lung cancer | [ICD-11: 2C25] | P01111 | NRAS |
| T35486 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | P01111 | NRAS |
| T35486 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P01111 | NRAS |
| T32578 | DI0028 | Anemia | [ICD-11: 3A00-3A9Z] | P05231 | IL6 |
| T99641 | DI0396 | Substance abuse | [ICD-11: 6C40] | P30837 | ALDH1B1 |